NewEdge Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.9M | Sell |
183,368
-25,953
| -12% | -$2.49M | 0.06% | 324 |
|
|
2025
Q4 | $20.1M | Buy |
209,321
+8,213
| +4% | +$798K | 0.07% | 249 |
|
|
2025
Q3 | $19.2M | Buy |
201,108
+64,905
| +48% | +$5.97M | 0.09% | 231 |
|
|
2025
Q2 | $11.9M | Sell |
136,203
-81,417
| -37% | -$6.9M | 0.06% | 326 |
|
|
2025
Q1 | $19.6M | Buy |
217,620
+18,964
| +10% | +$1.7M | 0.12% | 184 |
|
|
2024
Q4 | $15.9M | Buy |
198,656
+28,672
| +17% | +$2.48M | 0.1% | 208 |
|
|
2024
Q3 | $15.3M | Buy |
169,984
+47,104
| +38% | +$3.96M | 0.1% | 210 |
|
|
2024
Q2 | $9.67M | Buy |
122,880
+8,127
| +7% | +$666K | 0.07% | 273 |
|
|
2024
Q1 | $10M | Buy |
114,753
+10,431
| +10% | +$890K | 0.09% | 226 |
|
|
2023
Q4 | $8.78M | Buy |
104,322
+8,317
| +9% | +$634K | 0.08% | 227 |
|
|
2023
Q3 | $7.52M | Buy |
96,005
+4,797
| +5% | +$402K | 0.08% | 237 |
|
|
2023
Q2 | $8.04M | Sell |
91,208
-3,286
| -3% | -$283K | 0.09% | 226 |
|
|
2023
Q1 | $7.76M | Buy |
94,494
+5,941
| +7% | +$484K | 0.1% | 218 |
|
|
2022
Q4 | $4.09M | Sell |
88,553
-811
| -0.9% | -$65.7K | 0.11% | 206 |
|
|
2022
Q3 | $7.22M | Buy |
89,364
+4,290
| +5% | +$386K | 0.12% | 184 |
|
|
2022
Q2 | $7.63M | Buy |
85,074
+10,160
| +14% | +$1.03M | 0.13% | 171 |
|
|
2022
Q1 | $8.31M | Buy |
74,914
+13,895
| +23% | +$1.47M | 0.13% | 164 |
|
|
2021
Q4 | $6.31M | Buy |
61,019
+31,707
| +108% | +$3.67M | 0.1% | 209 |
|
|
2021
Q3 | $3.67M | Sell |
29,312
-1,845
| -6% | -$239K | 0.09% | 208 |
|
|
2021
Q2 | $3.87M | Buy |
31,157
+3,163
| +11% | +$397K | 0.1% | 197 |
|
|
2021
Q1 | $3.31M | Buy |
27,994
+3,207
| +13% | +$376K | 0.1% | 203 |
|
|
2020
Q4 | $2.9M | Sell |
24,787
-43,543
| -64% | -$4.79M | 0.1% | 199 |
|
|
2020
Q3 | $7.1M | Buy |
68,330
+31,242
| +84% | +$3.14M | 0.25% | 98 |
|
|
2020
Q2 | $3.4M | Buy |
37,088
+24,988
| +207% | +$2.4M | 0.13% | 154 |
|
|
2020
Q1 | $1.09M | Sell |
12,100
-620
| -5% | -$66K | 0.05% | 295 |
|
|
2019
Q4 | $1.44M | Buy |
12,720
+859
| +7% | +$94.3K | 0.06% | 296 |
|
|
2019
Q3 | $1.29M | Buy |
11,861
+3,722
| +46% | +$388K | 0.06% | 297 |
|
|
2019
Q2 | $793K | Buy |
8,139
+50
| +0.6% | +$4.57K | 0.05% | 307 |
|
|
2019
Q1 | $737K | Buy |
8,089
+2,015
| +33% | +$180K | 0.05% | 317 |
|
|
2018
Q4 | $553 | Sell |
6,074
-753
| -11% | -$70.4K | 0.04% | 355 |
|
|
2018
Q3 | $672K | Buy |
6,827
+1,169
| +21% | +$108K | 0.05% | 297 |
|
|
2018
Q2 | $487 | Sell |
5,658
-524
| -8% | -$43.8K | 0.04% | 315 |
|
|
2018
Q1 | $479K | Sell |
6,182
-376
| -6% | -$31K | 0.05% | 277 |
|
|
2017
Q4 | $561K | Sell |
6,558
-1,138
| -15% | -$91.1K | 0.08% | 221 |
|
|
2017
Q3 | $592K | Buy |
7,696
+2,857
| +59% | +$237K | 0.09% | 195 |
|
|
2017
Q2 | $422K | Buy |
+4,839
| New | +$408K | 0.07% | 210 |
|
|
2016
Q4 | – | Sell |
-3,301
| Closed | -$285K | – | 276 |
|
|
2016
Q3 | $285K | Buy |
+3,301
| New | +$288K | 0.09% | 177 |
|
Other funds holding MDT
VCM
VPM
NewEdge Advisors's MDT Position: Q1 2026 in Review
NewEdge Advisors reduced its Medtronic (MDT) stake by 12% in Q1 2026, selling an estimated $2.49M and leaving 183,368 shares worth $15.9M. The position accounts for 0.06% of the portfolio, ranked #324.
NewEdge Advisors first reported a position in MDT in Q3 2016 and has held it in 37 quarters since. The position peaked at $20.1M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- NewEdge Advisors held 183,368 shares of Medtronic worth $15.9M as of Q1 2026.
- NewEdge Advisors sold 25,953 Medtronic shares in Q1 2026, an estimated $2.49M.
- Medtronic made up 0.06% of NewEdge Advisors's portfolio in Q1 2026, its #324 holding.
- NewEdge Advisors first reported a position in Medtronic in Q3 2016 and has held it in 37 quarters since.
- NewEdge Advisors's Medtronic position peaked at $20.1M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.